Compare Sana Biotechnology Inc (SANA) vs Schwab US Large Cap Growth ETF (SCHG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sana Biotechnology Inc vs Schwab US Large Cap Growth ETF — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $1.03B), while Schwab US Large Cap Growth ETF trades at $35.04. The key difference: Schwab US Large Cap Growth ETF is trading nearer its 52-week high, Sana Biotechnology Inc nearer its low. Which is the better fit depends on your goals.
| SANA | SCHG | |
|---|---|---|
Market Cap | $1.03B | — |
Sector | Health | Sector/Thematic |
52-Week High | $5.92 | $35.94 |
52-Week Low | $2.68 | $28.10 |
Enterprise Value | $946.04M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SANA Biotechnology trades at $3.45, down 10.39% in the past 24 hours, reflecting bearish technical signals and negative profitability. The company reported a net loss of $244.17 million for 2025, with a price-to-book ratio of 6.68. Recent news includes investor conference presentations and a peer-reviewed publication in The New England Journal of Medicine highlighting clinical data.
Despite analyst consensus favoring a 'Buy' rating (81.82% of 11 analysts), the stock faces significant risks from negative cash flows, high losses, and potential fiduciary concerns. Upside hinges on successful clinical developments and improved financial performance, but current fundamentals suggest caution for investors.
SCHG trades at $35.25, down 0.79% today, with a bullish technical signal from moving averages and neutral oscillators. The ETF maintains strong institutional interest and offers exposure to large-cap growth stocks at a competitive expense ratio. Recent news highlights SCHG's historical outperformance versus the S&P 500 and ongoing comparisons with peers like QQQM and VUG.
Long-term growth potential remains supported by SCHG's track record, though concentration risk in top holdings and market volatility pose challenges. The ETF's low-cost structure and growth focus present opportunities for investors seeking diversified large-cap exposure, but requires monitoring of valuation levels and sector rotations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →About Schwab US Large Cap Growth ETF
SCHG is an ETF that seeks to track the total return of the Dow Jones U.S. Large-Cap Growth Total Stock Market Index. The fund provides low-cost exposure to a diversified portfolio of large-capitalization U.S. companies that are classified as growth stocks based on factors such as sales, earnings, and book value growth rates. SCHG is often used by investors seeking long-term capital appreciation from market-leading companies with above-average growth potential.
Read more on SCHG →
